Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Related Citations for PubMed (Select 24446510)

1.

Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation.

Gaita F, Sardi D, Battaglia A, Gallo C, Toso E, Michielon A, Caponi D, Garberoglio L, Castagno D, Scaglione M.

Europace. 2014 Jul;16(7):980-6. doi: 10.1093/europace/eut406. Epub 2014 Jan 19.

PMID:
24446510
2.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

3.

The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Themistoclakis S, Corrado A, Marchlinski FE, Jais P, Zado E, Rossillo A, Di Biase L, Schweikert RA, Saliba WI, Horton R, Mohanty P, Patel D, Burkhardt DJ, Wazni OM, Bonso A, Callans DJ, Haissaguerre M, Raviele A, Natale A.

J Am Coll Cardiol. 2010 Feb 23;55(8):735-43. doi: 10.1016/j.jacc.2009.11.039.

4.

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.

Disertori M, Franzosi MG, Barlera S, Cosmi F, Quintarelli S, Favero C, Cappellini G, Fabbri G, Maggioni AP, Staszewsky L, Moroni LA, Latini R; GISSI-AF investigators.

BMC Cardiovasc Disord. 2013 Apr 15;13:28. doi: 10.1186/1471-2261-13-28.

5.

Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.

Saad EB, d'Avila A, Costa IP, Aryana A, Slater C, Costa RE, Inácio LA Jr, Maldonado P, Neto DM, Camiletti A, Camanho LE, Polanczyk CA.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):615-21. doi: 10.1161/CIRCEP.111.963231. Epub 2011 Aug 13.

6.

CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.

Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.

Europace. 2014 Feb;16(2):202-7. doi: 10.1093/europace/eut210. Epub 2013 Jun 28.

7.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

8.

Incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation guided by complex fractionated atrial electrogram.

Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, Ninomiya Y, Matsushita T, Miyata M, Hamasaki S, Tei C.

J Cardiovasc Electrophysiol. 2012 Jun;23(6):567-73. doi: 10.1111/j.1540-8167.2011.02259.x. Epub 2012 Feb 7.

PMID:
22313240
9.

Incidence of late thromboembolic events after catheter ablation of atrial fibrillation.

Yagishita A, Takahashi Y, Takahashi A, Fujii A, Kusa S, Fujino T, Nozato T, Kuwahara T, Hirao K, Isobe M.

Circ J. 2011;75(10):2343-9. Epub 2011 Jul 21.

10.

Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

Europace. 2014 Feb;16(2):195-201. doi: 10.1093/europace/eut244. Epub 2013 Sep 12.

11.

Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.

Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A.

Circulation. 2014 Jun 24;129(25):2638-44. doi: 10.1161/CIRCULATIONAHA.113.006426. Epub 2014 Apr 17.

PMID:
24744272
12.

Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A.

Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7. doi: 10.1161/CIRCEP.113.001182. Epub 2014 Mar 8.

PMID:
24610790
13.

Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.

Apostolakis S, Lane DA, Buller H, Lip GY.

Thromb Haemost. 2013 Nov;110(5):1074-9. doi: 10.1160/TH13-07-0552. Epub 2013 Sep 19.

PMID:
24048467
14.

Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

J Interv Card Electrophysiol. 2013 Dec;38(3):147-53. doi: 10.1007/s10840-013-9835-1. Epub 2013 Oct 8.

15.

The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.

Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, Namino F, Ninomiya Y, Miyata M, Hamasaki S, Tei C.

Pacing Clin Electrophysiol. 2013 Nov;36(11):1328-35. doi: 10.1111/pace.12195. Epub 2013 Aug 16.

PMID:
23952291
16.

Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences.

Kornej J, Hindricks G, Banerjee A, Arya A, Sommer P, Rolf S, Husser D, Lip GY, Bollmann A.

Heart. 2015 Jan;101(2):126-31. doi: 10.1136/heartjnl-2014-306013. Epub 2014 Oct 3.

PMID:
25281600
17.

[Association between CHADS2 score and long-term atrial fibrillation recurrence rate after catheter ablation].

Hu X, Wang Q, Sun J, Feng X, Zhang P, Liu B, Wang J, Zhang R, Li Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 May;42(5):379-83. Chinese.

PMID:
25042914
18.

Asymptomatic cerebral lesions during pulmonary vein isolation under uninterrupted oral anticoagulation.

Martinek M, Sigmund E, Lemes C, Derndorfer M, Aichinger J, Winter S, Jauker W, Gschwendtner M, Nesser HJ, Pürerfellner H.

Europace. 2013 Mar;15(3):325-31. doi: 10.1093/europace/eus329. Epub 2012 Oct 24.

19.

Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.

Riley MP, Zado E, Hutchinson MD, Lin D, Bala R, Garcia FC, Callans DJ, Cooper JM, Verdino RJ, Dixit S, Marchlinski FE.

J Cardiovasc Electrophysiol. 2014 Jun;25(6):591-6. doi: 10.1111/jce.12387. Epub 2014 Mar 10.

PMID:
24533561
20.

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.

Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.

PMID:
22473219
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk